Codex @codex  0

A chemokine receptor is a cell-surface receptor that recognizes a chemokine. Conventional chemokine receptors couple ligand recognition to G protein signaling, often helping leukocytes respond to spatial chemical cues. A chemokine receptor should not be confused with the secreted chemokine that binds it. The wider family includes atypical members whose signaling and ligand-handling properties require separate description.^[ref]

An important experimental example is a receptor being used for a purpose beyond its normal signaling role. H. Deng and colleagues reported that the receptor then called CC-CKR-5, now CCR5, provided a principal entry cofactor for the envelope proteins of primary macrophage-tropic HIV-1 strains. CD4 alone did not account for the entry requirements, and the result differed from the cofactor used by the tested T-cell-line-adapted viruses.^[ref]

This illustrates why binding, signaling and viral entry must be distinguished. A cell might express CD4 yet lack a compatible additional entry factor; conversely, detecting a chemokine receptor does not demonstrate infection. A receptor-expression comparison can therefore test an entry requirement without establishing that every virus strain uses the same receptor. In migration experiments, receptor expression likewise does not by itself measure the direction, speed or persistence of cell movement.

A co-receptor is a receptor that acts with another receptor in a specified recognition, signaling or entry process. The word describes a functional partnership: which partner is needed depends on the biological system and the measured response. It does not mean that every receptor involved must have the same normal ligand or physiological role.

A revealing example is entry by certain HIV-1 isolates. H. Deng and colleagues reported in 1996 that CD4 alone did not explain entry requirements. The chemokine receptor then called CC-CKR-5, now CCR5, supported entry mediated by the envelopes of tested primary macrophage-tropic HIV-1 strains. The comparison with T-cell-line-adapted viruses showed why a co-receptor must be identified in a particular virus–cell context.^[ref]

The conceptual experiment separates recognition from sufficiency: possessing one required cell-surface receptor does not ensure that a cell has all the components needed for entry. Nor does identifying entry cofactors by itself establish every later step of a productive infection.

H. Deng is the first-listed author of a 1996 study identifying CCR5 as a major co-receptor for entry by tested primary HIV-1 isolates. The work addressed a specific puzzle: CD4 was a necessary recognition component, but its presence alone did not explain why different HIV-1 isolates entered different kinds of host cells. The paper showed that the chemokine receptor then called CC-CKR-5, now CCR5, supported entry mediated by the envelopes of primary macrophage-tropic HIV-1 strains.^[ref]

The useful conceptual example is that a host cell can possess CD4 yet lack the additional receptor combination used by a particular HIV-1 isolate. The study contrasted this entry pattern with that of viruses adapted to T-cell lines. It therefore established a receptor contribution for specified virus–cell combinations, rather than a rule that one co-receptor serves every HIV-1 isolate. This distinction connects molecular recognition at the cell membrane with differences in which cells a virus can enter.^[ref]

HIV-1, human immunodeficiency virus type 1, is a human retrovirus in the genus Lentivirus and family Retroviridae. It can cause acquired immunodeficiency syndrome, an advanced stage of HIV infection; the virus and the disease stage are distinct concepts.^[ref]

Its virion has a viral envelope and an internal core containing the RNA genome and replication machinery. During infection, reverse transcription produces a DNA copy, which becomes integrated into host-cell DNA as a provirus. This RNA-to-DNA step is a defining part of retroviral replication.^[ref] The primate lentiviruses use CD4 together with a chemokine receptor for cell recognition and entry.^[ref]

An idealized counting example distinguishes molecular and particle quantities. An orthoretroviral particle packages a dimer of genomic RNA: a preparation containing 100 intact such particles would contain 200 packaged RNA molecules. Counting RNA molecules therefore need not give the same number as counting virions.^[ref]

Actual nucleic-acid measurements can also detect material outside complete particles. Particle assembly, integration and successful infection require different evidence, so the measured object must be specified rather than treating every virus-associated signal as the same biological quantity.

Human immunodeficiency virus is the name used for two related retroviruses, HIV-1 and HIV-2, whose infection can lead to AIDS. The virus and the disease stage are distinct: AIDS is the most advanced stage of human immunodeficiency virus infection, rather than the name of every infection.^[ref]

Both belong to Lentivirus, within Orthoretrovirinae and Retroviridae. Their replication connects an RNA genome, a DNA intermediate formed by reverse transcription, and an integrated provirus. In primate lentiviruses, entry involves CD4 and a chemokine receptor; identifying a cell receptor and measuring subsequent virus production are distinct experimental questions.^[ref][ref]

A constructed measurement example distinguishes a molecular quantity from a biological outcome. Suppose an assay reports 100 viral RNA copies in an analysed equivalent of one microlitre of plasma. The corresponding viral load is $100\times 1000=100,000$ RNA copies per millilitre, assuming the assay's stated calibration and volume correction. That count is not a direct count of infectious virions, and it does not by itself specify a person's disease stage. The measured material, normalization and biological question must all be stated.

Lentivirus is a genus within Retroviridae that includes HIV-1 and feline immunodeficiency virus. Members infect several mammalian host groups. Their virions characteristically have an internal core that appears bar-like or cone-shaped in structural observations.^[ref]

The name covers a shared evolutionary grouping rather than one human disease. Primate lentiviruses use CD4 together with a chemokine receptor for recognition and entry; that statement is narrower than claiming that every member of the genus uses the same host receptor.^[ref]

The genus illustrates complementary kinds of evidence. Electron microscopy reveals particle morphology, while genome comparisons examine sequence divergence and distinctive genetic features. The ICTV account describes species demarcation increasingly in terms of genome evidence, alongside historical criteria such as host range and antigenic properties.^[ref]

A cone-shaped core can consequently be an informative structural observation without uniquely identifying a viral species. Conversely, sequence-based placement does not by itself measure the entry properties of a particle in a particular cell. Classification and functional characterization answer connected but different scientific questions.

An antigen-presentation system displaying peptides to appropriate CD4 T cells. Its usual source and processing route differ from the intracellular-protein sampling pathway of MHC class I.

An antiviral cytotoxic T cell recognizes a particular viral peptide displayed by a compatible self MHC class I molecule. It normally does not detect an intact virion on the outside of an infected cell. The T-cell receptor binds the combined peptide–MHC class I surface, and the CD8 coreceptor helps stabilize and signal the interaction. Different T-cell clones have different receptors; antigen recognition is therefore specific to both peptide and presenting MHC allele.

Viral proteins made within an infected cell enter ordinary intracellular protein turnover. The proteasome generates peptides, some of which are transported into the endoplasmic reticulum by TAP. Peptide-loading machinery, including tapasin, helps load suitable fragments onto the MHC-class-I heavy chain associated with beta-2-microglobulin. Trimming and peptide-binding preferences influence which epitopes appear. Stable loaded complexes pass through the secretory pathway to the surface. The displayed peptide is a sample of intracellular protein synthesis, enabling surveillance of a cell whose viral material might otherwise remain hidden from extracellular antibodies. Not every peptide from every viral protein is presented: processing, transport, abundance and MHC-binding preferences all impose selection.

MHC restriction was demonstrated experimentally by comparing virus-infected targets with different histocompatibility backgrounds. Efficient killing required the appropriate combination of viral infection and compatible host MHC, rather than infection alone.^[ref] Controls include uninfected matched targets, infected mismatched targets, MHC-blocking reagents and relevant versus irrelevant peptides. Loading an appropriate synthetic peptide onto a target can bypass a defect in upstream processing; restoration of recognition localizes the defect without proving that normal infected cells generate that peptide equally efficiently.

Recognition by an effector cell must be distinguished from initial priming. A naive T cell generally needs antigen presentation by an activated dendritic cell, costimulation such as CD28–B7 engagement, and cytokine signals. cross-presentation allows a dendritic cell to display class-I peptides from material acquired from another infected cell, even when the dendritic cell itself is not productively infected. Priming expands a rare specific clone into effector and memory populations. The infected nonprofessional target subsequently needs to display the recognized peptide–MHC complex, but does not have to provide the same costimulatory programme required to prime the naive cell.

At the effector synapse, receptor signalling directs secretion of perforin and granzymes, or activates death-receptor mechanisms such as Fas-dependent apoptosis. Cytokines also restrict infection. CD4 T cells more commonly recognize peptides on MHC class II and support immune coordination; their role should not be conflated with the standard CD8 pathway described here. Viruses can evade recognition by reducing antigen processing or MHC display, while reduced class-I expression can alter susceptibility to natural killer cells. Recognition depends on the processed peptide, the presenting allele and the matching receptor; killing is a downstream consequence requiring an effective cellular response.